SCHEMBL19465243

SCHEMBL19465243

COCCCc1ccc(C(F)(F)F)cc1OC#N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.37
KCNH2 Q12809 6/20 0.37
SLC6A4 P31645 5/20 0.37
HTR2A P28223 4/20 0.37
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 1/20 0.36
HTT P42858 2/20 0.36
KDM4E B2RXH2 2/20 0.36
KMT2A Q03164 2/20 0.36
CTSK P43235 1/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
ESRRA P11474 2/20 0.35
PPARG P37231 2/20 0.34
HPGD P15428 1/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15731295 0.76 CFTR (0.44) TRPV1KCNH2SLC6A4ALDH1A1HSD17B10
SCHEMBL5685349 0.73 CASP1 (0.45) HTR2AHSD17B10KMT2AESRRACYP3A4
SCHEMBL19465218 0.73 TAAR1 (0.35) SLC6A4
SCHEMBL15716429 0.72 TRPV1 (0.39) TRPV1KCNH2SLC6A4ALDH1A1HSD17B10
SCHEMBL3787060 0.70 SLC6A4 (0.44) KCNH2SLC6A4HTR2ACYP2D6MRGPRX4
SCHEMBL11959864 0.68 TAAR1 (0.52) KCNH2SLC6A4KMT2ACYP1A2CYP3A4
SCHEMBL6681553 0.67 PPARG (0.44) KCNH2SLC6A4HTR2APPARGPPARD
SCHEMBL18608786 0.67 KDM4E (0.45) SLC6A4ALDH1A1HSD17B10HTTKDM4E
SCHEMBL10233689 0.67 KDM4E (0.54) TRPV1ALDH1A1HSD17B10HTTKDM4E
SCHEMBL22265222 0.66 ANO1 (0.43) KCNH2SLC6A4HTR2AKMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790210-B2 N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors ARRAY BIOPHARMA INC. (US) 2017-10-17 US disclosed